Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × UNKNOWN × Breast Neoplasms × Clear all

Phase

Phase 2 18 Phase 3 6 Phase NA 4 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

OTHER 67 INDUSTRY 18 OTHER_GOV 3 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 2 Tuberculosis 1 Sarcoidosis 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Cough 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01150513 2021-02-09

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer

ChineseAMS

Phase 2/3 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡